🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

UK stocks close down after data dashes hopes of early rate cuts

Published 13/02/2024, 08:23
© Reuters. Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/File Photo
GBP/USD
-
UK100
-
FLG
-
FTMC
-
GB10YT=RR
-

By Shristi Achar A and Sruthi Shankar

(Reuters) -The main UK stock indexes suffered sharp falls on Tuesday after hotter-than-expected U.S. inflation numbers and domestic wages data prompted investors to scale back expectations of early interest rate cuts this year.

The blue-chip FTSE 100 closed down 0.8%, its biggest one-day selloff in almost a month.

Britain's rate-sensitive homebuilders tumbled 4.0% and REITs fell 2.4%, leading losses among the FTSE 350 subsectors.

U.S. and European government bond yields surged after a report showed consumer inflation stayed elevated last month, smashing market expectations of imminent interest rate cuts by the Federal Reserve.

Data earlier showed British wage growth slowed by less than forecast in the three months to the end of 2023, pushing investors to price in the first quarter-point rate cut from the Bank of England no sooner than June. [0#BOEWATCH]

All eyes will be on the UK inflation numbers on Wednesday.

"The range of outcomes is wider than usual due to weight changes but tomorrow's number could end the recent run of downside surprises at say 4.1% versus 4%, mainly due to base effects," said Kevin Boscher, chief investment officer at Ravenscroft.

"Markets may be disappointed tomorrow but all components of inflation are declining rapidly and inflation could positively surprise markets and the MPC and be back at 2% by April/May."

The domestically focussed FTSE 250 dropped 1.5% to also post its worst day in nearly a month.

Among individual stocks, GSK (LON:GSK) added 0.9% after Citigroup upgraded the stock for the first time in seven years, on positive results from a study for its multiple myeloma drug, Blenrep.

© Reuters. Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/File Photo

AstraZeneca (NASDAQ:AZN) rose 1.0% following four consecutive sessions of losses, providing a boost to the market.

London-listed shares of TUI (LON:TUIT) gave up early gains to close down 0.2% after Europe's largest travel operator swung to a profit in its first quarter.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.